53 related articles for article (PubMed ID: 1283325)
1. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.
Ransom DT; Ritland SR; Moertel CA; Dahl RJ; O'Fallon JR; Scheithauer BW; Kimmel DW; Kelly PJ; Olopade OI; Diaz MO
Genes Chromosomes Cancer; 1992 Nov; 5(4):357-74. PubMed ID: 1283325
[TBL] [Abstract][Full Text] [Related]
2. Hsp27 (HSPB1): a possible surrogate molecular marker for loss of heterozygosity (LOH) of chromosome 1p in oligodendrogliomas but not in astrocytomas.
Castro GN; Cayado-Gutiérrez N; Moncalero VL; Lima P; De Angelis RL; Chávez V; Cuello-Carrión FD; Ciocca DR
Cell Stress Chaperones; 2012 Nov; 17(6):779-90. PubMed ID: 22806482
[TBL] [Abstract][Full Text] [Related]
3. Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH.
Ichimura K; Mungall AJ; Fiegler H; Pearson DM; Dunham I; Carter NP; Collins VP
Oncogene; 2006 Feb; 25(8):1261-71. PubMed ID: 16205629
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
McAleenan A; Jones HE; Kernohan A; Robinson T; Schmidt L; Dawson S; Kelly C; Spencer Leal E; Faulkner CL; Palmer A; Wragg C; Jefferies S; Brandner S; Vale L; Higgins JP; Kurian KM
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013387. PubMed ID: 35233774
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.
Brandner S; McAleenan A; Jones HE; Kernohan A; Robinson T; Schmidt L; Dawson S; Kelly C; Leal ES; Faulkner CL; Palmer A; Wragg C; Jefferies S; Vale L; Higgins JPT; Kurian KM
Neuropathol Appl Neurobiol; 2022 Jun; 48(4):e12790. PubMed ID: 34958131
[TBL] [Abstract][Full Text] [Related]
6. Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer.
Ramalingam S; Ramamoorthy P; Subramaniam D; Anant S
Immunogastroenterology; 2012; 1(1):27-33. PubMed ID: 23795348
[TBL] [Abstract][Full Text] [Related]
7. Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype.
Goldhoff P; Clarke J; Smirnov I; Berger MS; Prados MD; James CD; Perry A; Phillips JJ
J Neuropathol Exp Neurol; 2012 Jan; 71(1):83-9. PubMed ID: 22157621
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of allelic losses on chromosome 10 in human gliomas at recurrence.
Tokiyoshi K; Yoshimine T; Maruno M; Muhammad AK; Hayakawa T
Clin Mol Pathol; 1996 Aug; 49(4):M218-22. PubMed ID: 16696078
[TBL] [Abstract][Full Text] [Related]
9. Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables.
Zhou YH; Hess KR; Liu L; Linskey ME; Yung WK
Neuro Oncol; 2005 Oct; 7(4):485-94. PubMed ID: 16212813
[TBL] [Abstract][Full Text] [Related]
10. PAX6 suppresses growth of human glioblastoma cells.
Zhou YH; Wu X; Tan F; Shi YX; Glass T; Liu TJ; Wathen K; Hess KR; Gumin J; Lang F; Yung WK
J Neurooncol; 2005 Feb; 71(3):223-9. PubMed ID: 15735909
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of oligodendroglial tumors.
Jeuken JW; von Deimling A; Wesseling P
J Neurooncol; 2004 Nov; 70(2):161-81. PubMed ID: 15674476
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of allelic losses in brain tumours using microsatellite repeat markers and high-performance liquid chromatography.
Chernova OB; Barnett GH; Cowell JK
Br J Cancer; 2003 Jun; 88(12):1889-93. PubMed ID: 12799632
[TBL] [Abstract][Full Text] [Related]
13. Rig is a novel Ras-related protein and potential neural tumor suppressor.
Ellis CA; Vos MD; Howell H; Vallecorsa T; Fults DW; Clark GJ
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9876-81. PubMed ID: 12107278
[TBL] [Abstract][Full Text] [Related]
14. Investigation of genetic alterations associated with development and adverse outcome in patients with astrocytic tumor.
Cianciulli AM; Morace E; Coletta AM; Occhipinti E; Gandolfo GM; Leonardo G; Carapella CM
J Neurooncol; 2000 Jun; 48(2):95-101. PubMed ID: 11083072
[TBL] [Abstract][Full Text] [Related]
15. Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours.
Miyakawa A; Ichimura K; Schmidt EE; Varmeh-Ziaie S; Collins VP
Br J Cancer; 2000 Feb; 82(3):543-9. PubMed ID: 10682663
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.
Gibbs M; Stanford JL; McIndoe RA; Jarvik GP; Kolb S; Goode EL; Chakrabarti L; Schuster EF; Buckley VA; Miller EL; Brandzel S; Li S; Hood L; Ostrander EA
Am J Hum Genet; 1999 Mar; 64(3):776-87. PubMed ID: 10053012
[TBL] [Abstract][Full Text] [Related]
17. Deletion mapping of chromosome 10 in human glioma.
Sonoda Y; Murakami Y; Tominaga T; Kayama T; Yoshimoto T; Sekiya T
Jpn J Cancer Res; 1996 Apr; 87(4):363-7. PubMed ID: 8641967
[TBL] [Abstract][Full Text] [Related]
18. A clonal translocation t(10;21) in an optic glioma of a patient with neurofibromatosis type 1 (NF 1).
Kehrer H; Krone W; Braun V; Richter HP
Acta Neurochir (Wien); 1995; 133(1-2):101-4. PubMed ID: 8561028
[TBL] [Abstract][Full Text] [Related]
19. Growth of cultured human glioma tumour cells can be regulated with histamine and histamine antagonists.
Van der Ven LT; Prinsen IM; Jansen GH; Roholl PJ; Defferrari R; Slater R; Den Otter W
Br J Cancer; 1993 Sep; 68(3):475-83. PubMed ID: 8353038
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses.
Schröck E; Thiel G; Lozanova T; du Manoir S; Meffert MC; Jauch A; Speicher MR; Nürnberg P; Vogel S; Jänisch W
Am J Pathol; 1994 Jun; 144(6):1203-18. PubMed ID: 8203461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
